OPKO Receives FDA Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder Mar 22, 2017
OPKO Receives EU Orphan Drug Status for its New Oligonucleotide to Treat Genetic Neurological Disorder Mar 8, 2017
OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development Mar 3, 2017
OPKO Health’s GeneDx Announces Participation in Illumina’s iHope Program on International Rare Disease Day Feb 28, 2017
